Distinct genomic profiles useful for clinical diagnosis and therapy
Cold Spring Harbor, NY — The first high-resolution analysis of genomic alterations in breast tumors is reported today in the scientific journal Genome Research. In this analysis, scientists from Cold Spring Harbor Laboratory, in collaboration with researchers from Scandinavia, identified three distinct patterns of genomic variation that underlie breast tumor formation, one of which—‘firestorms’—may be predictive of aggressive disease progression and short survival.
“‘Firestorms’ are violent genomic disruptions that lead to destructive forms of breast cancer, even when the rest of the genome is relatively quiet,” explains Dr. Jim Hicks, Senior Research Investigator at Cold Spring Harbor Laboratory and lead author on the paper.
Large-scale DNA alterations in cancer cells—rearrangements, deletions, and duplications—may assist in the proliferation and progression of the disease. “A thorough understanding of these changes will allow the design of more rational therapies,” says Hicks. “Doctors will be able to recommend an appropriate course of treatment—hormonal therapy or chemotherapy—based on a patient’s genomic profile.”
Using a high-resolution genomic profiling technique called ROMA (Representational Oligonucleotide Microarray Analysis), the scientists tested genomic DNA samples from 243 breast tumor samples acquired from the Karolinska Institute (Sweden) and the Oslo Micrometastasis Study (Norway). The samples were from patients whose clinical history had been documented, which allowed the scientists to associate the genomic profiles with clinical outcomes.
Most strikingly, Hicks and his co-workers found ‘firestorms’ of genomic amplification—tight chromosomal clusters where DNA segments had undergone multiple rounds of breakage, copying, and rejoining in a concerted manner. ‘Firestorms’ were found in 25% of the breast cancer samples and were associated with negative clinical outcomes. The amplifications were generally limited to single chromosomal arms and were flanked by broad segments of low-copy-number duplications and deletions.
Another complex genomic profile, called ‘sawtooth,’ was present in 5% of breast cancer samples. It was characterized by narrow, low-copy-number deletions and duplications that were evenly distributed across the chromosomes. The ‘simplex’ profile, affecting 60% of the tumor samples, exhibited broad genomic duplications and deletions that only affected a single chromosomal arm. The remaining 10% of the samples exhibited a ‘flat’ profile, reflecting normal levels of copy number variation in the genome.
In addition to potential clinical applications, the profiles described in this study will be useful for assessing the relationship between ‘firestorms’ and the locations of candidate oncogenes and tumor suppressors in the genome. It will assist the researchers in identifying genes that drive cancer progression, and help unravel the complex yet elusive genetic pathway that underlies tumor metastasis.
The work was conducted by Hicks and his colleagues in Dr. Michael Wigler’s lab at Cold Spring Harbor Laboratory in collaboration with researchers from Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Ullevål University Hospital, Memorial Sloan-Kettering Cancer Center, and Karolinska Institute. It was funded by grants from the National Institutes of Health, Dept. of the Army, Simons Foundation, Miracle Foundation, Breast Cancer Research Foundation, Long Islanders Against Breast Cancer, West Islip Breast Cancer Foundation, Long Island Breast Cancer, Elizabeth McFarland Breast Cancer Research, Breast Cancer Help, Inc., Swedish Cancer Society, Stockholm Cancer Society, and Norwegian Cancer Society.
Dr. James Hicks, lead investigator on the project, has agreed to be contacted (firstname.lastname@example.org; +1-516-367-8382) for additional information.
Genome Research is an international, continuously published, peer-reviewed journal published by Cold Spring Harbor Laboratory Press. Launched in 1995, it is one of the five most highly cited primary research journals in genetics and genomics.
Cold Spring Harbor Laboratory Press is an internationally renowned publisher of books, journals, and electronic media, located on Long Island, New York. It is a division of Cold Spring Harbor Laboratory, an innovator in life science research and the education of scientists, students, and the public. For more information, visit www.cshlpress.com.
Interested reporters may obtain pre-print copies of the manuscript from Peggy Calicchia, Editorial Secretary, Genome Research (email@example.com). The paper’s full citation is as follows:
Hicks, J., Krasnitz, A., Lakshmi, B., Navin, N., Riggs, M., Leibu, E., Esposito, D., Alexander, J., Troge, J., Grubor, V., Wigler, M., Børresen-Dale, A.-L., Naume, B., Schlicting, E., Norton, L., Hägerström, T., Skoog, L., Auer, G., Månér, S., Lundin, P., and Zetterberg, A. 2006. “Novel patterns of genome rearrangement and their association with survival in breast cancer.” Genome Res. 16: 1465-1479. [DOI: 10.1101/gr.5460106]
About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,100 people including 600 scientists, students and technicians. The Meetings & Courses Program annually hosts more than 12,000 scientists. The Laboratory’s education arm also includes an academic publishing house, a graduate school and the DNA Learning Center with programs for middle and high school students and teachers. For more information, visit www.cshl.edu